These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6922790

  • 1. Surfactant treatment in experimental hyaline membrane disease.
    Nilsson R, Grossmann G, Berggren P, Robertson B.
    Eur J Respir Dis; 1981 Dec; 62(6):441-9. PubMed ID: 6922790
    [Abstract] [Full Text] [Related]

  • 2. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease.
    Nilsson R.
    Acta Anaesthesiol Scand; 1982 Apr; 26(2):89-103. PubMed ID: 7048842
    [Abstract] [Full Text] [Related]

  • 3. Review of experimental hyaline membrane disease.
    Robertson B.
    Diagn Histopathol; 1981 Apr; 4(1):49-60. PubMed ID: 7018865
    [Abstract] [Full Text] [Related]

  • 4. Effect of supplementary surfactant on in vivo lung mechanics in the premature rabbit neonate.
    Lachmann B, Grossman G, Nilsson R, Robertson B.
    Eur J Pediatr; 1981 May; 136(2):173-9. PubMed ID: 7014223
    [Abstract] [Full Text] [Related]

  • 5. Lung expansion in premature newborn rabbits treated with emulsified synthetic surfactant; principles for experimental evaluation of synthetic substitutes for pulmonary surfactant.
    Grossmann G, Larsson I, Nilsson R, Robertson B, Rydhag L, Stenius P.
    Respiration; 1984 May; 45(4):327-38. PubMed ID: 6566397
    [Abstract] [Full Text] [Related]

  • 6. Artificial ventilation of premature newborn rabbits: effects of positive end-expiratory pressure on lung mechanics and lung morphology.
    Nilsson R, Grossmann G, Robertson B.
    Acta Paediatr Scand; 1980 Sep; 69(5):597-602. PubMed ID: 7015781
    [Abstract] [Full Text] [Related]

  • 7. Combined effects of surfactant substitution and prolongation of inspiration phase in artificially ventilated premature newborn rabbits.
    Lachmann B, Berggren P, Curstedt T, Grossmann G, Robertson B.
    Pediatr Res; 1982 Nov; 16(11):921-7. PubMed ID: 6760100
    [Abstract] [Full Text] [Related]

  • 8. Bronchiolar epithelial lesions induced in the premature rabbit neonate by short periods of artificial ventilation.
    Nilsson R, Grossmann G, Robertson B.
    Acta Pathol Microbiol Scand A; 1980 Nov; 88(6):359-67. PubMed ID: 7211384
    [Abstract] [Full Text] [Related]

  • 9. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
    J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
    [Abstract] [Full Text] [Related]

  • 10. Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs.
    Morley C, Robertson B, Lachmann B, Nilsson R, Bangham A, Grossmann G, Miller N.
    Arch Dis Child; 1980 Oct; 55(10):758-65. PubMed ID: 7002050
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of neonatal lung lesions induced by artificial ventilation: evidence against the role of barotrauma.
    Nilsson R, Grossmann G, Robertson B.
    Respiration; 1980 Oct; 40(4):218-25. PubMed ID: 6894337
    [Abstract] [Full Text] [Related]

  • 12. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J, Aebi C, Bachmann D, Wagner BP.
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [Abstract] [Full Text] [Related]

  • 13. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH, Deverajan LV, Curstedt T, Robertson B.
    Biol Neonate; 1990 Sep; 58(3):121-6. PubMed ID: 2279046
    [Abstract] [Full Text] [Related]

  • 14. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model.
    Maeta H, Raju TN, Vidyasagar D, Bhat R, Esterly J, Matsuda H, Shimada S, Krukenkamp IB, Shanklin DR.
    Crit Care Med; 1990 Apr; 18(4):403-9. PubMed ID: 2318051
    [Abstract] [Full Text] [Related]

  • 15. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
    Häfner D, Germann PG.
    J Pharmacol Toxicol Methods; 1999 Apr; 41(2-3):97-106. PubMed ID: 10598681
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 17. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 18. Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates.
    Cutz E, Enhörning G, Robertson B, Sherwood WG, Hill DE.
    Am J Pathol; 1978 Sep; 92(3):581-94. PubMed ID: 99046
    [Abstract] [Full Text] [Related]

  • 19. Pathology of neonatal surfactant deficiency.
    Robertson B.
    Perspect Pediatr Pathol; 1987 Sep; 11():6-46. PubMed ID: 3110733
    [No Abstract] [Full Text] [Related]

  • 20. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Cotton RB, Olsson T, Law AB, Parker RA, Lindstrom DP, Silberberg AR, Sundell HW, Sandberg K.
    Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.